Clinical trial of new AhR inhibitor shows cancer might be even more wily than we thought
The human immune system is constantly attacking damaged cells that might turn into cancer, thus protecting us from these cells growing out of control and becoming malignant. However, cancer cells have many ways of protecting themselves from the body’s immune system. One of these is a protein, called aryl hydrocarbon receptor (AhR), which is common on tumor and immune cells. When AhR is activated, it causes immunosuppression and promotes...
Your questions about BCMA and multiple myeloma, answered
You may have heard someone with multiple myeloma mention the possibility of BCMA-targeted therapy and wondered what BCMA means and why it...